Can a simple ointment make surgical scars heal better?
NCT ID NCT03561376
First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time
Summary
This trial tests whether zinc oxide ointment improves scar healing compared with plain petrolatum after skin surgery. Adults with a surgical cut at least 4.5 cm long on non-scalp skin will apply each ointment to half of the scar daily for a month. Researchers will compare scar appearance, healing speed, and infection rates over six months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Topical zinc oxide ointment compared with petrolatum (Vaseline) applied daily to healing surgical scars.
- What this could lead to
- If zinc oxide proves better, it could become a simple, cheap way to improve scar appearance and reduce complications after skin surgery.
- What could go wrong
- This is a small early-phase study, so results may not apply to everyone. Zinc oxide can cause skin irritation or allergic reactions in some people.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2021
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. ≥ 18 years of age 2. Linear closure, non-scalp site 3. ≥ 4.5 cm in length (final incision/closure length) 4. End to end symmetry (surgical site is not grossly asymmetric from end to end) 5. Grossly uninfected site Exclusion Criteria: 1. ≤ 18 years 2. Visibly asymmetric linear scar 3. Grossly infected surgical site 4. History of allergy to topical zinc oxide
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hypertrophic scar are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
UPMC Dermatology St. Margaret
RECRUITINGPittsburgh, PA, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Analgesic requirement for Post-Operative pain control in elective 1-3 level transforaminal lumbar interbody fusion: comparison of thoracolumbar interfascial plane block with exparel to bupivacaine HCl
- Can a simple triangle on the face prevent nerve damage in jaw surgery?
- Propofol vs. inhaled anesthesia: which one spares your recovery?
- One injection after neck surgery: a new test for better scar healing
- Can a 100,000-Patient global audit reveal how to make surgery safer?
- Which wound closure cuts infection risk after abdominal surgery?